Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial and viral adhesion to host cell is the initial step in microbial infection, involving the binding of pathogen-produced adhesion molecules (adhesins) to specific receptors or molecules on the surface of host cells. This process can involve protein-protein, protein-carbohydrate, or protein-lipid interactions. Bacterial adhesins include pili, fimbriae, and surface glycoproteins, often targeting extracellular matrix components like collagen or fibronectin. Viruses typically use viral envelope or capsid proteins to bind host cell receptors such as heparan sulfate proteoglycans, integrins, or immunoglobulin-like adhesion molecules. Successful adhesion is a prerequisite for colonization, entry, and initiation of infection, making individual components of this process important therapeutic targets or vaccine candidates, although "bacterial and viral adhesion to host cell" itself is not a single molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial and viral adhesion to host cell.